Latest Opioid Stories
RICHMOND, Va., April 7, 2014 /PRNewswire/ -- Kaleo (formerly Intelliject) today announced that it has entered into a $150 million debt facility with PDL BioPharma (NASDAQ: PDLI) to enable kaleo to
SAN DIEGO, April 4, 2014 /PRNewswire/ -- Today, Health and Human Services (HHS) Secretary Kathleen Sebelius, and U.S. Food and Drug Administration (FDA) Commissioner Dr.
First and only naloxone product specifically intended for emergency administration by family members or caregivers in settings where opioids may be present RICHMOND, Va., April 3, 2014 /PRNewswire/
SAN DIEGO, April 2, 2014 /PRNewswire/ -- We are extremely disappointed that the U.S.
SAN DIEGO, March 27, 2014 /PRNewswire/ -- We agree with Governor Deval Patrick's intention to curb the epidemic of drug abuse in Massachusetts.
Developers Continue to Focus Efforts on Formulation Improvements, According to Findings from Decision Resources Group BURLINGTON, Mass., March 17, 2014 /PRNewswire/ -- Decision Resources Group
Two-thirds of states include methadone on preferred drug lists for Medicaid patients PHOENIX, March 7, 2014 /PRNewswire-USNewswire/ -- Two-thirds of states prefer methadone above other
Researchers sought comprehensive predictors of opioid abuse in veterans based on discontinuation rates PHOENIX, March 6, 2014 /PRNewswire-USNewswire/ -- Of nearly 1 million veterans
Composition of Matter Patents Issued in Multiple Countries for KemPharm's Lead Abuse-Deterrent Hydrocodone Prodrug CORALVILLE, Iowa, March 4, 2014 /PRNewswire/ -- KemPharm, Inc., a
Photoreactive compounds developed by LMU scientists directly modulate nerve-cell function, and open new routes to the treatment of neurological diseases, including chronic pain and certain types of visual impairment.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.